Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats.

OBJECTIVES To test a non-glycosylated recombinant human bone morphogenetic protein-2 (ngly-rhBMP-2)/fibrin composite, which has been shown experimentally to enhance healing of bone defects in rodents, in a clinical case series of dogs and cats undergoing treatment for fracture non-unions and arthrodesis. METHODS A ngly-rhBMP-2/fibrin composite was applied in 41 sites in 38 dogs and cats for which a cancellous bone autograft was indicated, replacing the graft. RESULTS Bridging of the bone defect with functional bone healing was achieved in 90 per cent of the arthrodesis and fracture nonunions treated in this manner. CLINICAL SIGNIFICANCE This prospective clinical study demonstrates the beneficial effects of ngly-rhBMP-2 in a specially designed fibrin matrix on the treatment of bone defects, and validates the use of this composite as an alternative to bone autografts in dogs and cats.

[1]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[2]  D. Chamberland,et al.  Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. , 1998, Journal of biomedical materials research.

[3]  S. Cook,et al.  Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. , 1994, Clinical orthopaedics and related research.

[4]  Ralph Müller,et al.  Bone healing in the rat and dog with nonglycosylated BMP‐2 demonstrating low solubility in fibrin matrices , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  M. Flückiger,et al.  Healing of dorsal pancarpal arthrodesis in the dog. , 2003, The Journal of small animal practice.

[6]  E. Burger,et al.  Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. , 2002, Bone.

[7]  F. Rauch,et al.  Bone morphogenetic proteins in orthopedics: from basic science to clinical practice. , 1999, Orthopedics.

[8]  J. Wozney,et al.  Mandibular Reconstruction Using Bone Morphogenetic ProteinLong‐Term Follow‐up in a Canine Model , 1999, The Laryngoscope.

[9]  M. Mochizuki,et al.  Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. , 1998, The Journal of veterinary medical science.

[10]  H F Sailer,et al.  Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. , 2002, International journal of oral and maxillofacial surgery.

[11]  M. Magin,et al.  Improved Lumbar Vertebral Interbody Fusion Using rhOP-1: A Comparison of Autogenous Bone Graft, Bovine Hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in Sheep , 2001, Spine.

[12]  J. Hubbell,et al.  Effects of fibrinolysis on neurite growth from dorsal root ganglia cultured in two‐ and three‐dimensional fibrin gels , 1996, The Journal of comparative neurology.

[13]  H. Buettner,et al.  Degradation of extracellular matrix by neuronal proteases. , 1989, Developmental neuroscience.

[14]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[15]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[16]  J. Wozney,et al.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.

[17]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[18]  C. Kirker-Head,et al.  Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing. , 1995, Veterinary surgery : VS.

[19]  J H Brekke,et al.  Principles of tissue engineering applied to programmable osteogenesis. , 1998, Journal of biomedical materials research.

[20]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[21]  H. Seeherman,et al.  The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog model , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  P. Griss,et al.  Cell differentiation under the influence of rh-BMP-2. , 2001, Biochemical and biophysical research communications.